Beam Therapeutics, Inc. (BEAM)
27.57
-0.27
(-0.97%)
USD |
NASDAQ |
Dec 30, 10:26
Beam Therapeutics Shareholders Equity (Quarterly): 966.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 505.82M |
| Intellia Therapeutics, Inc. | 748.42M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Amicus Therapeutics, Inc. | 230.42M |
| Repligen Corp. | 2.083B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.311B |
| Total Liabilities (Quarterly) | 345.08M |
| Debt to Equity Ratio | 0.1567 |
| Current Ratio | 6.018 |
| Net Debt Paydown Yield | 0.11% |